ALLK
Price
$0.32
Change
-$0.00 (-0.00%)
Updated
Apr 3, 02:28 PM (EDT)
Capitalization
28.98M
34 days until earnings call
IMCR
Price
$29.27
Change
-$0.17 (-0.58%)
Updated
Apr 3, 02:41 PM (EDT)
Capitalization
1.47B
34 days until earnings call
Ad is loading...

ALLK vs IMCR

Header iconALLK vs IMCR Comparison
Open Charts ALLK vs IMCRBanner chart's image
Allakos
Price$0.32
Change-$0.00 (-0.00%)
Volume$3.2K
Capitalization28.98M
Immunocore Holdings
Price$29.27
Change-$0.17 (-0.58%)
Volume$300
Capitalization1.47B
ALLK vs IMCR Comparison Chart
Loading...
ALLK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALLK vs. IMCR commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLK is a Hold and IMCR is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (ALLK: $0.32 vs. IMCR: $29.43)
Brand notoriety: ALLK and IMCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLK: 699% vs. IMCR: 182%
Market capitalization -- ALLK: $28.98M vs. IMCR: $1.47B
ALLK [@Biotechnology] is valued at $28.98M. IMCR’s [@Biotechnology] market capitalization is $1.47B. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLK’s FA Score shows that 1 FA rating(s) are green whileIMCR’s FA Score has 0 green FA rating(s).

  • ALLK’s FA Score: 1 green, 4 red.
  • IMCR’s FA Score: 0 green, 5 red.
According to our system of comparison, ALLK is a better buy in the long-term than IMCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLK’s TA Score shows that 4 TA indicator(s) are bullish while IMCR’s TA Score has 3 bullish TA indicator(s).

  • ALLK’s TA Score: 4 bullish, 4 bearish.
  • IMCR’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, both ALLK and IMCR are a good buy in the short-term.

Price Growth

ALLK (@Biotechnology) experienced а +39.21% price change this week, while IMCR (@Biotechnology) price change was -0.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.69%. For the same industry, the average monthly price growth was -9.74%, and the average quarterly price growth was -14.08%.

Reported Earning Dates

ALLK is expected to report earnings on May 07, 2025.

IMCR is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-7.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMCR($1.47B) has a higher market cap than ALLK($29M). IMCR YTD gains are higher at: -0.237 vs. ALLK (-73.446). IMCR has higher annual earnings (EBITDA): -29.89M vs. ALLK (-111.04M). IMCR has more cash in the bank: 820M vs. ALLK (80.8M). ALLK has less debt than IMCR: ALLK (4.16M) vs IMCR (433M). IMCR has higher revenues than ALLK: IMCR (310M) vs ALLK (0).
ALLKIMCRALLK / IMCR
Capitalization29M1.47B2%
EBITDA-111.04M-29.89M371%
Gain YTD-73.446-0.23730,952%
P/E RatioN/AN/A-
Revenue0310M-
Total Cash80.8M820M10%
Total Debt4.16M433M1%
FUNDAMENTALS RATINGS
ALLK: Fundamental Ratings
ALLK
OUTLOOK RATING
1..100
87
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALLKIMCR
RSI
ODDS (%)
Bearish Trend 1 day ago
85%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
N/A
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 16 days ago
85%
Bullish Trend 8 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 10 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
81%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
80%
View a ticker or compare two or three
Ad is loading...
ALLK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BRUGX15.470.11
+0.72%
MFS Blended Research Value Equity C
ARTGX24.110.09
+0.37%
Artisan Global Value Investor
FBPEX26.51N/A
N/A
Cantor Fitzgerald Equity Div Plus Inst
STDFX38.04N/A
N/A
Allspring Large Cap Growth Admin
GQGRX16.51N/A
N/A
GQG Partners Emerging Markets Equity R6

ALLK and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLK has been loosely correlated with VERU. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ALLK jumps, then VERU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLK
1D Price
Change %
ALLK100%
+48.06%
VERU - ALLK
46%
Loosely correlated
-0.78%
AXON - ALLK
38%
Loosely correlated
+3.18%
IMCR - ALLK
33%
Loosely correlated
+2.79%
AMRN - ALLK
32%
Poorly correlated
-2.26%
GANX - ALLK
31%
Poorly correlated
+4.42%
More

IMCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMCR has been loosely correlated with CRBU. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if IMCR jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMCR
1D Price
Change %
IMCR100%
+2.79%
CRBU - IMCR
38%
Loosely correlated
+2.37%
IMNM - IMCR
37%
Loosely correlated
+7.19%
SPRB - IMCR
37%
Loosely correlated
+9.21%
KYMR - IMCR
37%
Loosely correlated
+4.46%
IDYA - IMCR
36%
Loosely correlated
+10.70%
More